B12 injections provide a boost of this essential nutrient, promoting healthier, stronger, and more vibrant skin, hair, and nails
Research has identified B12 as a potentially beneficial intervention for core symptoms in Long COVID and ME/CFS patients
Daily Dose: 2.67 mg (equivalent to 10 units / 0.10 mL), maintained throughout the full cycle Frequency: Administer once daily via subcutaneous injection, ideally at the same time each day Cycle Duration: 4-16 weeks of continuous use, followed by a 24 week break to assess response and support receptor recovery Injection Volume: Approximately 0.10 mL per dose, well within typical comfort limits for subcutaneous delivery (generally under 1.01.5 mL) Syringe Guidance: A 0.3 mL (30-unit) U-100 insulin syringe is recommended for improved accuracy when measuring small volumes Storage Instructions Proper storage is essential to maintain peptide stability and integrity
Produced primarily in the liver, glutathione acts as a key player in various metabolic processes, helping to neutralize free radicals and toxins that can damage cells
The extensive preclinical research foundation, favorable preclinical safety profile, and preliminary human experience suggest BPC-157 warrants continued investigation as a potential therapeutic agent for tissue repair and regeneration